Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7P32

Crystal structure of human lysosomal acid-alpha-glucosidase, GAA, in complex with cyclosulfamidate 6

これはPDB形式変換不可エントリーです。
7P32 の概要
エントリーDOI10.2210/pdb7p32/pdb
関連するPDBエントリー7P2Z
分子名称Lysosomal alpha-glucosidase, GLYCEROL, 1,2-ETHANEDIOL, ... (13 entities in total)
機能のキーワードalpha-glycosidase, lysosomal, pompe disease, pharmacological chaperone, hydrolase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計100880.06
構造登録者
Roig-Zamboni, V.,Kok, K.,Overkleeft, H.,Artola, M.,Sulzenbacher, G. (登録日: 2021-07-06, 公開日: 2022-07-13, 最終更新日: 2024-11-13)
主引用文献Kok, K.,Kuo, C.L.,Katzy, R.E.,Lelieveld, L.T.,Wu, L.,Roig-Zamboni, V.,van der Marel, G.A.,Codee, J.D.C.,Sulzenbacher, G.,Davies, G.J.,Overkleeft, H.S.,Aerts, J.M.F.G.,Artola, M.
1,6- epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal alpha-Glucosidase Stabilizer for the Treatment of Pompe Disease.
J.Am.Chem.Soc., 144:14819-14827, 2022
Cited by
PubMed Abstract: α-Glucosidase inhibitors are potential therapeutics for the treatment of diabetes, viral infections, and Pompe disease. Herein, we report a 1,6--cyclophellitol cyclosulfamidate as a new class of reversible α-glucosidase inhibitors that displays enzyme inhibitory activity by virtue of its conformational mimicry of the substrate when bound in the Michaelis complex. The α-d-configured cyclophellitol cyclosulfamidate binds in a competitive manner the human lysosomal acid α-glucosidase (GAA), ER α-glucosidases, and, at higher concentrations, intestinal α-glucosidases, displaying an excellent selectivity over the human β-glucosidases GBA and GBA2 and glucosylceramide synthase (GCS). Cyclosulfamidate stabilizes recombinant human GAA (rhGAA, alglucosidase alfa, Myozyme) in cell medium and plasma and facilitates enzyme trafficking to lysosomes. It stabilizes rhGAA more effectively than existing small-molecule chaperones and does so , , and in zebrafish, thus representing a promising therapeutic alternative to Miglustat for Pompe disease.
PubMed: 35917590
DOI: 10.1021/jacs.2c05666
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.82 Å)
構造検証レポート
Validation report summary of 7p32
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon